Compare DBVT & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DBVT | VREX |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | France | United States |
| Employees | 90 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.2M | 783.5M |
| IPO Year | 2014 | 2016 |
| Metric | DBVT | VREX |
|---|---|---|
| Price | $9.02 | $18.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $36.51 | $18.90 |
| AVG Volume (30 Days) | 300.2K | ★ 592.3K |
| Earning Date | 10-28-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.26 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $5,636,000.00 | ★ $811,000,000.00 |
| Revenue This Year | N/A | $2.52 |
| Revenue Next Year | $1,837.59 | $3.97 |
| P/E Ratio | ★ N/A | $78.93 |
| Revenue Growth | ★ 35.77 | N/A |
| 52 Week Low | $8.63 | $9.09 |
| 52 Week High | $26.19 | $18.63 |
| Indicator | DBVT | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 37.71 | 31.12 |
| Support Level | $8.78 | $18.02 |
| Resistance Level | $12.41 | $18.61 |
| Average True Range (ATR) | 0.76 | 0.10 |
| MACD | -0.12 | -0.04 |
| Stochastic Oscillator | 0.97 | 14.68 |
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.